Expanded terminal sedation in end-of-life care
- PMID: 36543531
- PMCID: PMC10086483
- DOI: 10.1136/jme-2022-108511
Expanded terminal sedation in end-of-life care
Abstract
Despite advances in palliative care, some patients still suffer significantly at the end of life. Terminal Sedation (TS) refers to the use of sedatives in dying patients until the point of death. The following limits are commonly applied: (1) symptoms should be refractory, (2) sedatives should be administered proportionally to symptoms and (3) the patient should be imminently dying. The term 'Expanded TS' (ETS) can be used to describe the use of sedation at the end of life outside one or more of these limits.In this paper, we explore and defend ETS, focusing on jurisdictions where assisted dying is lawful. We argue that ETS is morally permissible: (1) in cases of non-refractory suffering where earlier treatments are likely to fail, (2) where gradual sedation is likely to be ineffective or where unconsciousness is a clinically desirable outcome, (3) where the patient meets all criteria for assisted dying or (4) where the patient has greater than 2 weeks to live, is suffering intolerably, and sedation is considered to be the next best treatment option for their suffering.While remaining two distinct practices, there is scope for some convergence between the criteria for assisted dying and the criteria for ETS. Dying patients who are currently ineligible for TS, or even assisted dying, should not be left to suffer. ETS provides one means to bridge this gap.
Keywords: Euthanasia; Pain Management; Palliative Care; Right to Die; Terminal Care.
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.
Conflict of interest statement
Competing interests: JS is a Bioethics Committee consultant for Bayer Pharmaceutical. There are no other COI.
Figures
Comment in
-
Expanded terminal sedation: too removed from real-world practice.J Med Ethics. 2023 Apr;49(4):267-268. doi: 10.1136/jme-2023-109016. Epub 2023 Feb 22. J Med Ethics. 2023. PMID: 36813550 No abstract available.
-
Implications of extended terminal sedation.J Med Ethics. 2023 Apr;49(4):265-266. doi: 10.1136/jme-2023-109019. Epub 2023 Feb 28. J Med Ethics. 2023. PMID: 36854626 No abstract available.
-
Suffering, existential distress and temporality in the provision of terminal sedation.J Med Ethics. 2023 Apr;49(4):263-264. doi: 10.1136/jme-2023-109018. Epub 2023 Mar 6. J Med Ethics. 2023. PMID: 36878674 No abstract available.
-
Expanded terminal sedation: dangerous waters.J Med Ethics. 2023 Apr;49(4):261-262. doi: 10.1136/jme-2023-109021. Epub 2023 Mar 9. J Med Ethics. 2023. PMID: 36894308 No abstract available.
-
Expanding choice at the end of life.J Med Ethics. 2023 Apr;49(4):269-270. doi: 10.1136/jme-2023-109081. J Med Ethics. 2023. PMID: 36958738 No abstract available.
References
-
- McIntyre A. The Stanford Encyclopaedia of Philosophy: Metaphysics Research Lab. In: Doctrine of double effect. Spring, Stanford University, 2019.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous